Family Medicine Doctors in Sterling, KS Accepting Medicare
2 Family Medicine doctors found. Showing 1 - 2
 Kristina Rose Darnauer, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 239 N Broadway Ave, Sterling, KS 67579 Phone: 620-278-2123 |
 James D Decker, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 239 N Broadway Ave, Sterling, KS 67579 Phone: 620-278-2123 Fax: 620-278-2712 |
News Archive
Exercise improves physical health, quality of life for breast cancer survivors
Researchers at The University of Texas M. D. Anderson Cancer Center have found that exercise decreases pain and helps breast cancer survivors feel healthier and increase participation in daily activities.
Researchers use nitrous oxide to unravel rapid function of antidepressant mechanisms
Ketamine is commonly used in emergency medicine as an anesthetic drug. Later it was discovered to have rapid-acting antidepressant effects, but the mechanisms by which ketamine alleviates depression are still unknown.
FDA accepts Shield Therapeutics' IND application to begin ST10 Phase 3 pivotal study for IDA treatment
Shield Therapeutics, an independent specialty pharmaceutical company focused on the development of mineral-derived hospital pharmaceuticals, today announces that the US Food and Drug Administration has accepted its Investigational New Drug application to initiate a Phase 3 pivotal study of ST10, its novel oral iron-replacement therapy, for the treatment of iron deficiency anaemia in pre-dialysis patients with chronic kidney disease. The Company plans to initiate the Phase 3 study in the US in H1 2014 and positive data would be the cornerstone of a subsequent NDA submission.
Empire State Building towers to go purple on 6th annual World Prematurity Day
The Empire State Building towers will light purple today in honor of the 6th annual World Prematurity Day (WPD) tomorrow. Parent groups and organizations worldwide join together on WPD to raise awareness of the serious problem of premature birth.
Intellect Neurosciences: Several significant stakeholders commit funds
Intellect Neurosciences, Inc., a biopharmaceutical company focused on development of disease-modifying therapeutic agents for Alzheimer's disease ("AD"), announced today that several of its significant shareholders (the "Interested Shareholders") have agreed in principle to provide interim funding to the Company and assist the Company in its efforts to restructure its balance sheet.
› Verified 5 days ago